As shown in Figure 1D, two representative CLL patients with plasma samples collected after long-term treatment with ibrutinib (6, 12 and 18 months) confirmed the decrease of big ET-1. The gene discussed is EDN1; the disease is B-cell chronic lymphocytic leukemia.